The CytoSinct™ CD4 Nanobeads (human) are used for separating CD4+ cells from fresh or frozen peripheral blood mononuclear cells (PBMCs), leukapheresis products or single cell suspension based on the surface expression of human CD4. The surface of NanoBeads are labeled with anti-human CD4 monoclonal antibody. To begin the isolation, NanoBeads are added to the cells. The CD4 antibodies preconjugated to the NanoBeads can bind the target cells expressing CD4 on cell surface. The cells/beads mixed suspension is loaded onto a CytoSinct™ Column which is effectively magnetized by an external magnetic field from CytoSinct™ Magnet, or other compatible cell isolation columns and magnets. The NanoBeads-labeled CD4+ cells are retained within the column and enriched during the wash step when Isolation Buffer is used to flush out the CD4- cells. After removing magnetic field, the target CD4+ cells can be easily eluted from the column.

The CytoSinct™ CD8 Nanobeads (human) are used for separating CD8+ cells from fresh or frozen peripheral blood mononuclear cells (PBMCs), leukapheresis products or single cell suspension based on the surface expression of human CD8. The surface of Nanobeads are labeled with anti-human CD8 monoclonal antibody. To begin the isolation, Nanobeads are added to the cells. The CD8 antibodies preconjugated to the Nanobeads can bind the target cells expressing CD8 on cell surface. The cells/beads mixed suspension is loaded onto a CytoSinct™ Column which is effectively magnetized by an external magnetic field from CytoSinct™ Magnet, or other compatible cell isolation columns and magnets. The NanoBeads-labeled CD8+ cells are retained within the column and enriched during the wash step when Isolation Buffer is used to flush out the CD8- cells. After removing magnetic field, the target CD8+ cells can be easily eluted from the column.

The CytoSinct™ CD3 Nanobeads, human are used for separating CD3+ cells from fresh or frozen peripheral blood mononuclear cells (PBMCs), leukapheresis products or single cell suspension based on the surface expression of human CD3. The surface of Nanobeads are labeled with anti-human CD3 monoclonal antibody. To begin the isolation, Nanobeads are added to the cells. The CD3 antibodies preconjugated to the Nanobeads can bind the target cells expressing CD3 on cell surface. The cells/beads mixed suspension is loaded onto a CytoSinctTM Column which is effectively magnetized by an external magnetic field from CytoSinct™ Magnet, or other compatible cell isolation columns and magnets. The Nanobeads-labeled CD3+ cells are retained within the column and enriched during the wash step when Isolation Buffer is used to flush out the CD3- cells. After removing magnetic field, the target CD3+ cells can be easily eluted from the column.

The CytoSinctTM CD56 Nanobeads, human are used for separating CD56+ cells from fresh or frozen peripheral blood mononuclear cells (PBMCs), leukapheresis products or single cell suspension based on the surface expression of human CD56. The surface of Nanobeads are labeled with anti-human CD56 monoclonal antibody.